OBJECTIVE: Post @entity9 is a chronic, debilitating @entity158 with very few management options and is often refractory to treatment. We present our experience with a series of 4 @entity1 who underwent subcutaneous peripheral field stimulation for treatment of thoracic post herpetic @entity9 . METHODS: Four @entity1 with intractable thoracic post herpetic @entity9 were operated after maximum medical treatment and a neuropsychological evaluation. Multiple percutaneous electrodes were placed in the subcutaneous plane in the region of @entity158 for a 7-day trial. Following a successful trial (more than 50% reduction of @entity158 ), the electrodes were then internalized and attached to a pulse generator. Visual analog scores (VAS) were studied during the preoperative, immediate postoperative and last follow-up visits. Long-term treatment results were determined by retrospective review of medical records. Average follow-up period was 28.2 months. RESULTS: All 4 @entity1 showed persistent improvement in their VAS @entity158 scores with an average improvement of more than 75%. There were no treatment failures and no complication requiring re-operation was reported. CONCLUSION: Peripheral field stimulation for the treatment of post herpetic @entity9 is a safe and effective method for @entity158 relief for an extremely complex problem with very few solutions. @entity1 selection and proper lead placement is most important for the success of treatment.

Peripheral field stimulation for thoracic post herpetic XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'Patient'] @entity9 :: ('MESH:D009437', 'Disease') :: ['neuropathic pain', 'herpetic neuralgia'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain']
@entity9 :: (MESH:D009437,Disease) :: ['neuropathic pain']
